This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HMO Industry: Bullish Near-Term Outlook Despite Coronavirus Impact
by Sapna Bagaria
Health Insurers are likely to gain from higher demand for its products and services from senior citizens and the rising incidence of illness, partially offset by the COVID-19-led fallout.
HCA Healthcare (HCA) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
HCA Healthcare's (HCA) Q1 results are likely to reflect weak volumes from the coronavirus effect.
Molina Healthcare Gains on Sanders' Exit From Presidential Race
by Zacks Equity Research
Molina Healthcare (MOH) gains from Bernie Sanders' withdrawal from the presidential campaign.
UnitedHeath (UNH) Beats on Q1 Earnings, Dodges Coronavirus Curse
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings benefit from higher contribution at both its segments, escaping the fallout from the coronavirus-led crisis.
Molina (MOH) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Molina (MOH) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
7 Health Insurers Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.
Centene Soars 47.8% in Six Months: Will the Rally Continue?
by Zacks Equity Research
Centene's (CNC) strategic initiatives and higher membership might aid its revenues to perk up its share price in turn.
Is Molina Healthcare (MOH) Stock a Solid Choice Right Now?
by Zacks Equity Research
Molina Healthcare (MOH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Sanders Gives Health Insurers a Boost: Spotlight on 5 Stocks
by Tirthankar Chakraborty
Sanders' policies haven't been positive for health insurance stocks. He has favored Medicare-For-All and intended to abolish private insurance, which had cast a shadow on health insurance companies for months.
Molina Healthcare to Waive Costs Related to COVID-19 Treatment
by Zacks Equity Research
Molina Healthcare (MOH) eliminates specific 'out-of-pocket' expenses related to coronavirus treatment and undertakes several other initiatives.
Will Molina (MOH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Molina (MOH) Down 3.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana (HUM) Continues to Ride on Medicare Business Momentum
by Zacks Equity Research
Humana (HUM) consistently thrives on the back of its well-performing Medicare business.
Centene (CNC) Reduces 2020 Earnings Estimates, Shares Slide
by Zacks Equity Research
Centene (CNC) updates its 2020 outlook that reflects its WellCare buyout and the potential Medicaid rate decrease.
Cigna Ties Up With Houston Methodist to Provide Quality Care
by Zacks Equity Research
Cigna (CI) partners Houston Methodist to provide affordable health plans to its members.
Healthcare Sector to Remain Volatile in 2020 Amid Elections
by Sapna Bagaria
Disparity in the regulatory policies of presidential candidates of various parties renders volatility to the healthcare sector.
Molina Healthcare's (MOH) Q4 Earnings Surpass, Decline Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q4 earnings benefit from lower expenses, partly offset by a loss of Medicaid members.
Molina Healthcare (MOH) to Post Q4 Earnings: What to Expect
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter results are likely to reflect lower premium revenues and decline in medical membership.
Should You Buy Molina (MOH) Ahead of Earnings?
by Zacks Equity Research
Molina (MOH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Cigna (CI) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Cigna's (CI) earnings performance is likely to have gained from the accretive Express Scripts acquisition.
Centene's (CNC) Q4 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) fourth-quarter results gain traction from better revenues.
Molina (MOH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Centene's (CNC) Earnings in Q4?
by Zacks Equity Research
Centene's (CNC) Q4 earnings results are likely to reflect membership growth and better revenues.